Drug Topics March 2020

What new gaps will pharmacists need to fill?

It’s my hope that 2020 is a profession changing year, starting with the schools of pharmacy.

Analysts have forecasted the market for NASH drugs could reach $20 billion by 2025.

We asked pharmacists from various settings around the country: “Why did you become a pharmacist, and what keeps you motivated?"

From drug information to patient education, these apps can help you be better at everything that you do.

When looking to grow business with supplement sales, pharmacists should first educate themselves.

Relieving symptoms and optimizing therapies for allergic rhinitis

Pharmacy managers and educators offer career advice.

On December 23, 2019, the FDA approved ubrogepant for the acute treatment of migraine with and without aura in adult patients.

Approximately 1 million individuals are living with multiple sclerosis in the United States, according to the National MS Society.

Walk into a pharmacy in 2030 and there’s a good chance you’ll see a pharmacist. And there’s a good chance the pharmacist will have little or nothing to do with dispensing.

Creating a place where patients seek diabetes care and counseling.

FDA responds to shortages, plus other important updates.

Greg Jones, RPh, MBA, director of pharmacy services and his team are doing some amazing things in pharmacy.

A UMass Memorial telehealth-based program connects patients with credentialed clinicians who can prescribe medication-assisted treatment for opioid use disorder. 

What are some of the factors affecting whether a brand-name drug has generic competition?